ZALDIVA, INC.
331 EAST COMMERCIAL BLVD.
FT. LAUDERDALE, FLORIDA 33334
(954) 938-4133
July 7, 2010
Maryse Mills-Apenteng, Special Counsel
United States Securities and Exchange Commission
100 F Street, N.E.
Washington, DC 20549
Re:
Comment letter dated July 6, 2010, regarding the Preliminary Information
Statement on Schedule 14C of Zaldiva, Inc., a Florida corporation (the
“Company”)
Dear Ms. Mills-Apenteng:
I am writing in response to the above-referenced comment letter. The Company provides its response to your comment as set forth below:
1. Please discuss the possible anti-takeover effects of the increase in authorized shares o f common stock. Inform holders that management might use the additional shares to resist or frustrate a third-party transaction by, for example, diluting the stock ownership of persons seeking to obtain control of the company. Refer to Securities Exchange Act Release No. 34-15230.
The Company has filed a Revised Preliminary Information Statement on Schedule 14C in response to this comment. The requested information has been added in a new second paragraph under the heading “The Resolution – Amendment of the Company’s Articles of Incorporation to Increase the Authorized Common Stock from 50,000,000 Shares to 2,000,000,000 Shares.”
The Company acknowledges that:
·
The Company is responsible for the adequacy and accuracy of the disclosure in the filing;
·
Staff comments or changes to disclosure in response to staff comments do not foreclose the Commission from taking any action with respect to the filing; and
·
The Company may not assert staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
ZALDIVA, INC., a Florida corporation
By /s/ Nicole Leigh
Nicole Leigh, President
